xuliang: Clinical Trials

1 trial sponsored by xuliang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. .

Follow xuliang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer
Inavolisib in Combination With ET, Inavolisib in Combination With ET+CDK4/6i - Breast Cancer
Not yet recruitingxuliang1002026-05-162026-04-21

Conditions studied

Breast Neoplasms (1)

Interventions

inavolisib (1)

Results publications

PMID 39476340, PMID 40454641, PMID 41280894